Shoulder Innovations closed a US $2.5MM round of Series A equity funding to support new product development and growth of its inset glenoid technology, including acquisition of inventory and assets.
The company’s inset design, made to address glenoid loosening, is the foundation for future products in development as Shoulder Innovations pursues a complete shoulder arthroplasty line.
The round was led by the Michigan Angel Fund, Wakestream Ventures, Genesis Innovation Group, cultivate(MD) and other equity holders.
Source: Shoulder Innovations
Shoulder Innovations closed a US $2.5MM round of Series A equity funding to support new product development and growth of its inset glenoid technology, including acquisition of inventory and assets.
The company's inset design, made to address glenoid loosening, is the foundation for future products in development as Shoulder Innovations...
Shoulder Innovations closed a US $2.5MM round of Series A equity funding to support new product development and growth of its inset glenoid technology, including acquisition of inventory and assets.
The company’s inset design, made to address glenoid loosening, is the foundation for future products in development as Shoulder Innovations pursues a complete shoulder arthroplasty line.
The round was led by the Michigan Angel Fund, Wakestream Ventures, Genesis Innovation Group, cultivate(MD) and other equity holders.
Source: Shoulder Innovations
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





